Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Extended half-life recombinant factor VIII treatment of hemophilia A in Brazil: an expert consensus statement
Margareth Castro Ozelo; Sandra Vallin Antunes; Paula Ribeiro Villaca; Luciana Correa Oliveira; Ieda Solange Pinto; Claúdia Santos Lorenzato; Alessandra Nunes Loureiro Prezotti; Renato Mantelli Picoli;
Hematol Transfus Cell Ther. 2024;46:36-41
Minor surgical procedures during immune tolerance induction in people with hemophilia A and inhibitors: results from the Brazilian Immune Tolerance (BrazIT) study cohort
Ricardo Mesquita Camelo; Maíse Moreira Dias; Suely Meireles Rezende;
Hematol Transfus Cell Ther. 2024;46 Supl 5:S223-6
Epidemiology, patient journey and unmet needs related to hemophilia in Brazil: a scoping review with evidence map
Nayê Balzan Schneider; Cintia Laura Pereira de Araujo; Harryson Wings Godoy dos Santos; Simone Lima; Maicon Falavigna; Daniela Vianna Pachito;
Hematol Transfus Cell Ther. 2024;46:533-41